CNS Pharmaceuticals Inc (CNSP)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $5.09M
Last updated: Nov 17, 2026 at 4:10 PM ET
CNS Pharmaceuticals Inc (CNSP) Stock Chart
CNS Pharmaceuticals (CNSP) has a latest price of $4.15 on Nov 17, 2026, 60.6% below its 52-week high of $10.54. Its price fell 39.9% over the past 12 months. The month-end price fell 100.0% over the 5 years through Oct 2026, a compound annual decline of 91.7%.
Price Chart
From Nov 2019 to Oct 2026, its highest month-end close was $3,884,436.66 in Jan 2020 and its lowest $2.27 in Apr 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart CNSP with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CNSP.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 28.8%, and over 6 months it fell 13.2%. The month-end price fell 100.0% over the 3 years through Oct 2026, a compound annual decline of 95.7%.
| Period | Change |
|---|---|
| 1 month | -16.8% |
| 3 months | -28.8% |
| 6 months | -13.2% |
| 12 months | -39.9% |
| 12 months, with dividends | -39.9% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -100.0% | -95.7% |
| 5 years | -100.0% | -91.7% |
Price by Year
Its best calendar year was 2023, when the price fell 47.1%, and its weakest was 2024, when it fell 99.8%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $5.00 | -4.8% |
| 2025 | $5.25 | -92.7% |
| 2024 | $72.27 | -99.8% |
| 2023 | $38,115.25 | -47.1% |
| 2022 | $72,028.81 | -88.6% |
| 2021 | $633,046.01 | -60.5% |
| 2020 | $1,604,245.30 | -54.9% |
Trading Range
The price is 15.0% below its 50-day average of $4.88 and 6.7% below its 200-day average of $4.45.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $4.15 | |
| 52-week high | $10.54 | -60.6% |
| 52-week low | $1.90 | +118.4% |
| 50-day average | $4.88 | -15.0% |
| 200-day average | $4.45 | -6.7% |
Price Risk
Over 3 years, its largest fall from a peak was 100.0%.
| Measure | Value |
|---|---|
| 1-year beta | 0.05 |
| Largest fall, 1 year | -72.7% |
| Largest fall, 3 years | -100.0% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About CNSP
What is CNSP's 1-year price change?
CNS Pharmaceuticals's price fell 39.9% over the past 12 months. With dividends included, the 12-month total return was -39.9%.
What is CNSP's 5-year price change?
CNS Pharmaceuticals's month-end price fell 100.0% over the 5 years through Oct 2026, a compound annual decline of 91.7%. These figures leave out dividends.
What is CNSP's 52-week high and low?
CNS Pharmaceuticals's 52-week high is $10.54 and its 52-week low is $1.90. Its latest price of $4.15 on Nov 17, 2026 is 60.6% below the high.
What is CNSP's beta?
CNS Pharmaceuticals's 1-year beta against the S&P 500 is 0.05, so its price has shown little link to the market's moves over the past year. Its largest fall from a peak over the past year was 72.7%.
Is the CNSP chart free?
Yes. Advanced Charting for CNSP is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
CNSP pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors